Achieving social impact with private capital and hybrid financing models.

Charles Antoine Janssen shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors. Charles Antoine Janssen is vice chair of UCB, a global biopharmaceutical company headquartered in Belgium. And he's also managing partner of Kois https://koisinvest.com and Healthquad. Charles Antoine has experience in fundraising for social impact funds as well as investing the money raised in companies that want to solve societal problems. He shares his views on how investments aimed at improving the health of the most vulnerable populations in the world can still generate adequate financial returns for the investors. https://www.ucb.com https://healthquad.in